Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 5/20 | 0.64 |
| ▸ | NAALAD2 | Q9Y3Q0 | 4/20 | 0.64 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.64 |
| ▸ | GNPAT | O15228 | 1/20 | 0.54 |
| ▸ | GGH | Q92820 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29725450 | 1.00 | FOLH1 (0.64) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL709721 | 1.00 | FOLH1 (0.64) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL29171718 | 0.98 | FOLH1 (0.62) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| SCHEMBL29171721 | 0.98 | FOLH1 (0.62) | FOLH1NAALAD2RIMKLAGNPATGGH | |
| Boric Acid SCHEMBL29176392 | 0.94 | FOLH1 (0.58) | FOLH1NAALAD2RIMKLAGNPATCA2 | |
| SCHEMBL30565198 | 0.93 | FOLH1 (0.56) | FOLH1NAALAD2RIMKLAGNPAT | |
| SCHEMBL30099613 | 0.93 | FOLH1 (0.56) | FOLH1NAALAD2RIMKLAGNPAT | |
| SCHEMBL29893500 | 0.90 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGNPATCA2 | |
| SCHEMBL29557145 | 0.88 | FOLH1 (0.51) | FOLH1NAALAD2RIMKLAGNPAT | |
| SCHEMBL29349975 | 0.88 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGNPATCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119534671-A | Application of composition in preparation of medicines for diagnosing infantile hemangioma and/or monitoring progress and prognosis of infantile hemangioma | 江成鸿 | 2025-02-28 | — | — | CN | claimed |
| US-20240426830-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY | 2024-12-26 | — | — | US | claimed |
| US-20240168029-A1 | APPLICATION OF COMPOSITION IN PREPARATION OF DRUG FOR DIAGNOSING INFANTILE HEMANGIOMA AND/OR MONITORING PROGRESS AND PROGNOSIS THEREOF, AND KIT AND DRUG | JIANG CHENGHONG (CN) | 2024-05-23 | — | — | US | claimed |
| EP-4306960-A1 | APPLICATION OF COMPOSITION IN PREPARATION OF DRUG FOR DIAGNOSING INFANTILE HEMANGIOMA AND/OR MONITORING PROGRESS AND PROGNOSIS THEREOF, AND KIT AND DRUG | Jiang, Chenghong (CN) | 2024-01-17 | — | — | EP | claimed |
| CN-117043603-A | Application of composition in preparation of medicines for diagnosing infantile hemangioma and/or monitoring progress and prognosis of infantile hemangioma, kit and medicines | 江成鸿 | 2023-11-10 | — | — | CN | claimed |
| WO-2023069598-A1 | CHRONIC WOUND HEALING BIOMARKER DIAGNOSTICS | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2023-04-27 | — | — | WO | claimed |
| WO-2022188746-A1 | APPLICATION OF COMPOSITION IN PREPARATION OF DRUG FOR DIAGNOSING INFANTILE HEMANGIOMA AND/OR MONITORING PROGRESS AND PROGNOSIS THEREOF, AND KIT AND DRUG | 江成鸿 | 2022-09-15 | — | — | WO | claimed |
| CN-115032286-A | Application of composition in preparation of medicine for diagnosing infantile hemangioma and/or monitoring progression and prognosis of infantile hemangioma, kit and medicine | 江成鸿 | 2022-09-09 | — | — | CN | claimed |
| EP-2823033-A1 | CULTURE MEDIUM FOR EUKARYOTIC CELLS | Friesland Brands B.V. (NL) | 2015-01-14 | — | — | EP | claimed |
| EP-2823034-A1 | CULTURE MEDIUM FOR EUKARYOTIC CELLS | Friesland Brands B.V. (NL) | 2015-01-14 | — | — | EP | claimed |
| EP-1618117-A4 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | TRUSTEES EWHA WOMANS UNIVERSIT (KR) | 2007-04-11 | — | — | EP | claimed |
| EP-1618117-A1 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | Board of Trustees, Ewha Womans University (KR) | 2006-01-25 | — | — | EP | claimed |
| US-6951953-B2 | Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof | EWHA WOMANS UNIVERSITY (KR) | 2005-10-04 | — | — | US | claimed |
| WO-2004096820-A1 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | BOARD OF TRUSTEES, EWHA WOMANS UNIVERSITY (KR) | 2004-11-11 | — | — | WO | claimed |
| US-20040219127-A1 | Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof | EWHA WOMANS UNIVERSITY (KR) | 2004-11-04 | — | — | US | claimed |
| US-5757408-A | PRINTING IMAGE ON SUBSTRATE COATED WITH AMINO-ACID DERIVATIVE ADDITIVE; QUICK DRYING OF INK, OPTICAL DENSITY, NONCURLING | XEROX CORPORATION (US) | 1998-05-26 | — | — | US | claimed |
| US-5683793-A | Ink jet transparencies | XEROX CORPORATION (US) | 1997-11-04 | — | — | US | claimed |
| US-5589277-A | INK JET PRINTING, AQUEOUS INKS, FAST DRYING | XEROX CORPORATION (US) | 1996-12-31 | — | — | US | claimed |
| EP-0667246-A1 | Recording sheets containing amino acids, hydroxy acids, and polycarboxyl compounds | XEROX CORPORATION (US) | 1995-08-16 | — | — | EP | claimed |
| EP-0604945-A1 | TAN-1511, its derivatives, production and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-07-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040219127-A1 | Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof | PHOSPHO1, FOLR1, PCNA | FOLH1 76/4885NAALAD2 1813/4885RIMKLA 2449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.